Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak L Bhatt

Showing results (541-550 of 1,708) with videos related to

Pageof 171
Sort By:
American Journal of Preventive Cardiology|June 29, 2023
Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome: Analysis of EMPA-REG OUTCOME using REDUCE-IT criteriaSubodh Verma, Andrew Kosmopoulos, Deepak L Bhatt, et al.
JACC. Heart Failure|February 12, 2018
Impact of Body Mass Index on Heart Failure by Race/Ethnicity From the Get With The Guidelines-Heart Failure (GWTG-HF) RegistryTiffany M Powell-Wiley, Julius Ngwa, Selomie Kebede, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 28, 2016
Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension - Insights From the SYMPLICITY HTN-3 TrialKazuomi Kario, Deepak L Bhatt, David E Kandzari, et al.
CMAJ Open|May 2, 2017
Dipeptidyl peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysisSubodh Verma, Ronald M Goldenberg, Deepak L Bhatt, et al.
European Heart Journal|November 10, 2025
Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?Mattia Galli, Jurrien Ten Berg, Marco Valgimigli, et al.
American Journal of Preventive Cardiology|April 15, 2025
Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States populationRahul Aggarwal, Deepak L Bhatt, Marc P Bonaca, et al.
Journal of Cardiology|February 25, 2026
Discontinuation of statins by patient and physician sex: An observational studyAtsuyuki Watanabe, Yoshihisa Miyamoto, Hiroki A Ueyama, et al.
Cardiovascular Drugs and Therapy|February 16, 2024
A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty AcidsHani Sabbour, Deepak L Bhatt, Yaser Elhenawi, et al.
Heart Asia|June 22, 2016
Predictive value of high sensitivity C-reactive protein in the diagnosis and outcomes of acute aortic syndromesSoufian T AlMahameed, Gian M Novaro, Craig R Asher, et al.
American Heart Journal|February 28, 2016
Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery diseaseEmily C O'Brien, Jingjing Wu, Phillip J Schulte, et al.
Pageof 171

Showing results (541-550 of 1,708) with videos related to

Sort By:
Pageof 171
American Journal of Preventive Cardiology|June 29, 2023
Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome: Analysis of EMPA-REG OUTCOME using REDUCE-IT criteriaSubodh Verma, Andrew Kosmopoulos, Deepak L Bhatt, et al.
JACC. Heart Failure|February 12, 2018
Impact of Body Mass Index on Heart Failure by Race/Ethnicity From the Get With The Guidelines-Heart Failure (GWTG-HF) RegistryTiffany M Powell-Wiley, Julius Ngwa, Selomie Kebede, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 28, 2016
Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension - Insights From the SYMPLICITY HTN-3 TrialKazuomi Kario, Deepak L Bhatt, David E Kandzari, et al.
CMAJ Open|May 2, 2017
Dipeptidyl peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysisSubodh Verma, Ronald M Goldenberg, Deepak L Bhatt, et al.
European Heart Journal|November 10, 2025
Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?Mattia Galli, Jurrien Ten Berg, Marco Valgimigli, et al.
American Journal of Preventive Cardiology|April 15, 2025
Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States populationRahul Aggarwal, Deepak L Bhatt, Marc P Bonaca, et al.
Journal of Cardiology|February 25, 2026
Discontinuation of statins by patient and physician sex: An observational studyAtsuyuki Watanabe, Yoshihisa Miyamoto, Hiroki A Ueyama, et al.
Cardiovascular Drugs and Therapy|February 16, 2024
A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty AcidsHani Sabbour, Deepak L Bhatt, Yaser Elhenawi, et al.
Heart Asia|June 22, 2016
Predictive value of high sensitivity C-reactive protein in the diagnosis and outcomes of acute aortic syndromesSoufian T AlMahameed, Gian M Novaro, Craig R Asher, et al.
American Heart Journal|February 28, 2016
Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery diseaseEmily C O'Brien, Jingjing Wu, Phillip J Schulte, et al.
Pageof 171